Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03580928
Brief Title: Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)

First Submitted : June 25, 2018
First Submitted that Met QC Criteria : July 6, 2018
First Posted : July 10, 2018

Last Update Submitted that Met QC Criteria : December 9, 2018
Last Update Posted : December 11, 2018